References: 1. Stone RC, Stojadinovic O, Rosa AM, et al. A bioengineered living cell construct activates an acute wound healing response in venous leg ulcers. Sci Transl Med. 2017;9(371):eaa8611. doi:10.1126/scitranslmed.aaf8611. 2. Stone RC, Stojadinovic O, Sawaya AP, Rosa AM, Badiavas E, Blumenberg M, Tomic-Canic M. Treatment of chronic venous leg ulcers with bioengineered living cell construct induces metallothioneins and MMP8 to resolve matrix fibrosis and reactivates healthy remodeling response. Abstract presented at SAWC SPRING/WHS (2016). 3. Milstone LM, Asgari MM, Schwartz PM, Hardin-Young J. Growth factor expression, healing, and structural characteristics of Graftskin (Apligraf). Wounds. 2000;12 (5 Suppl A):12A-19A. 4. Falanga V, Isaacs C, Paquette D, et al. Wounding of bioengineered skin: cellular and molecular aspects after injury. J Invest Dermatol. 2002;119(3):653-660. 5. Brem H, Young J, Tomic-Canic M, Isaacs C, Ehrlich HP. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers. Surg Technol Int. 2003; 11:23-31. 6. Stone RC, Stojadinovic O, Sawaya AP, Glinos GD, Lindley LE, Pastar I, Badiavas E, Tomic-Canic M. A bioengineered living cell construct activates metallothionein/zinc/MMP8 and inhibits TGFβ to stimulate remodeling of fibrotic venous leg ulcers. Wound Rep Regen. 2019 Oct 31. doi: 10.1111/wrr.12778. [Epub ahead of print] 7. Apligraf [packaging insert]. Canton, MA: Organogenesis; 2017.
|